Sylvie Dijols - Concepedia

Concepedia

Author

Sylvie Dijols

Centre National de la Recherche Scientifique

Also Known As

Dijols, Sylvie, S. Dijols, Sylvie Dijols

27

Publications

1.1K

Citations

19

H-Index

26

Concepts

All Affiliations

Centre National de la Recherche Scientifique Université Paris Cité Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques Cleveland Clinic National Institutes of Health

SD

About

Sylvie Dijols is an author at Centre National de la Recherche Scientifique specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	660
2	Biochemistry	12	12	660
3	Natural Sciences	11	11	607
4	Chemical Biology	7	7	353
5	Metabolism	1	1	25

Sylvie Dijols

×

20

Publications

1.1K

Citations

19

H-Index

	Year	Citations
Structure of Mammalian Cytochrome P450 2C5 Complexed with Diclofenac at 2.1 Å Resolution: Evidence for an Induced Fit Model of Substrate Binding<sup>,</sup> Michael R. Wester, Eric F. Johnson, Cristina Marques‐Soares, Biochemistry Induced Fit ModelDrug TargetMolecular BiologyPharmaceutical ChemistryMolecular Pharmacology	2003	168
Ticlopidine as a Selective Mechanism-Based Inhibitor of Human Cytochrome P450 2C19 Nguyêt‐Thanh Ha‐Duong, Sylvie Dijols, Anne‐Christine Macherey, Biochemistry Molecular PharmacologyMedicinal ChemistryThiophene RingBiochemistrySelective Mechanism-based Inhibitor	2001	159
Interaction of Sulfaphenazole Derivatives with Human Liver Cytochromes P450 2C: Molecular Origin of the Specific Inhibitory Effects of Sulfaphenazole on CYP 2C9 and Consequences for the Substrate Binding Site Topology of CYP 2C9 Annah Mancy, Sylvie Dijols, Sonia Poli, Biochemistry	1996	122
The Substrate Binding Site of Human Liver Cytochrome P450 2C9: An Approach Using Designed Tienilic Acid Derivatives and Molecular Modeling Annah Mancy, P Lalueza Broto, Sylvie Dijols, Biochemistry	1995	112
Diclofenac and Its Derivatives As Tools for Studying Human Cytochromes P450 Active Sites: Particular Efficiency and Regioselectivity of P450 2Cs Annah Mancy, Marie Antignac, Claire Minoletti, Biochemistry	1999	76
Nω-Hydroxyamino-α-amino acids as a new class of very strong inhibitors of arginases J. Custot, Jean‐Luc Boucher, Sandrine Vadon‐Le Goff, JBIC Journal of Biological Inorganic Chemistry BiochemistryMedicineNω-hydroxyamino-α-amino AcidsMechanism Of ActionStrong Inhibitors	1996	53
Selective, competitive and mechanism-based inhibitors of human cytochrome P450 2J2 Pierre Lafite, Sylvie Dijols, Darryl C. Zeldin, Archives of Biochemistry and Biophysics Molecular PharmacologyMedicinal ChemistryBiochemistryMechanism-based InhibitorsMedicine	2007	52
<i>N</i>-Aryl <i>N</i>‘-Hydroxyguanidines, A New Class of NO-Donors after Selective Oxidation by Nitric Oxide Synthases: Structure−Activity Relationship Axelle Renodon‐Cornière, Sylvie Dijols, Céline Pérollier, Journal of Medicinal Chemistry	2001	51
Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2 Pierre Lafite, Sylvie Dijols, Didier Buisson, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDrug TargetBiochemistryMedicineNatural Sciences	2006	45
Reduction of Nilutamide by NO Synthases: Implications for the Adverse Effects of This Nitroaromatic Antiandrogen Drug Kjetil Ask, Sylvie Dijols, Claire Giroud, Chemical Research in Toxicology PharmacotherapyOxidative StressDrug ResistanceMedicinal ChemistryReactive Nitrogen Specie	2003	35

Page 1